Tirzepatide is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which helps regulate blood sugar levels, reduce appetite, and promote weight loss. Tirzepatide is also commonly used off-label as a weight management option in individuals without diabetes due to its effectiveness in supporting significant and sustained weight loss.